PT1200121E - Vacina - Google Patents

Vacina Download PDF

Info

Publication number
PT1200121E
PT1200121E PT00949768T PT00949768T PT1200121E PT 1200121 E PT1200121 E PT 1200121E PT 00949768 T PT00949768 T PT 00949768T PT 00949768 T PT00949768 T PT 00949768T PT 1200121 E PT1200121 E PT 1200121E
Authority
PT
Portugal
Prior art keywords
organism
fish
culture
produced
components
Prior art date
Application number
PT00949768T
Other languages
English (en)
Inventor
Andrew Cartner Barnes
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1200121(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918591.0A external-priority patent/GB9918591D0/en
Priority claimed from GBGB9923030.2A external-priority patent/GB9923030D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1200121E publication Critical patent/PT1200121E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT00949768T 1999-08-07 2000-08-07 Vacina PT1200121E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918591.0A GB9918591D0 (en) 1999-08-07 1999-08-07 Composition
GBGB9923030.2A GB9923030D0 (en) 1999-09-30 1999-09-30 Composition

Publications (1)

Publication Number Publication Date
PT1200121E true PT1200121E (pt) 2008-10-01

Family

ID=26315831

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00949768T PT1200121E (pt) 1999-08-07 2000-08-07 Vacina

Country Status (10)

Country Link
EP (1) EP1200121B2 (pt)
JP (2) JP4831905B2 (pt)
AT (1) ATE406911T1 (pt)
AU (1) AU6304000A (pt)
CY (1) CY1108781T1 (pt)
DE (1) DE60040153D1 (pt)
DK (1) DK1200121T3 (pt)
ES (1) ES2308987T5 (pt)
PT (1) PT1200121E (pt)
WO (1) WO2001010459A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317733D0 (en) 2003-07-29 2003-09-03 Novartis Ag Organic compounds
JP2006001849A (ja) * 2004-06-16 2006-01-05 Kochi Univ 魚類類結節症ワクチン
CN104736169B (zh) * 2012-09-10 2018-04-17 国立大学法人东京海洋大学 海产鱼的类结节病用dna疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403636D0 (sv) * 1994-10-24 1994-10-24 Ewos Ab Vaccine preparation

Also Published As

Publication number Publication date
CY1108781T1 (el) 2014-04-09
WO2001010459A3 (en) 2001-05-10
EP1200121B2 (en) 2012-05-09
WO2001010459A2 (en) 2001-02-15
ES2308987T3 (es) 2008-12-16
EP1200121A2 (en) 2002-05-02
DE60040153D1 (de) 2008-10-16
JP2011207888A (ja) 2011-10-20
DK1200121T3 (da) 2009-01-12
JP4831905B2 (ja) 2011-12-07
AU6304000A (en) 2001-03-05
ES2308987T5 (es) 2012-08-30
EP1200121B1 (en) 2008-09-03
JP2003506412A (ja) 2003-02-18
ATE406911T1 (de) 2008-09-15

Similar Documents

Publication Publication Date Title
ID22689A (id) Metode untuk mengaktifkan sel-sel yang menunjukan-sifat antigen manusia, sel-sel teraktifkan yang menunjukan sifat antigen manusia, dan penggunaannya
EP0400958A3 (en) Live vaccines
EP2067863A3 (en) Methods and compositions for diseases associated with amyloidosis
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
WO2004068931A3 (en) Amphiregulin antibodies and their use to treat cancer and psoriasis
AU7194101A (en) Treatment of glycogen storage disease type ii
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
SG45225A1 (en) A novel physiologically active substance
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
CY1108781T1 (el) Εμβολιο ψαριων
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
EA200100700A1 (ru) Гены и белки и их применение
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
SE9903534L (sv) Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
WO2003059262A3 (en) Method and composition for treating and preventing hiv infection and aids
SE0003958D0 (sv) Method for growth of microorganisms
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
PL370854A1 (en) Ee3-protein family and corresponding dna sequences
MX9708615A (es) Terapia de genes animales.
WO2001044278A3 (en) Antigen preparations
Hieu et al. Application of EM1 (effective microorganisms) for treatment of diarrheic disease in piglets in Vietnam
MXPA02010182A (es) Metodos de uso de penicilaminas para el tratamiento de condiciones que resultan del dano en el adn.
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
ATE508771T1 (de) Zytoprotektion durch phosphotyrosin
GEP20022659B (en) Process for Preparing Growth Hormone Secretagogues